Home Cart Sign in  
Chemical Structure| 120205-48-3 Chemical Structure| 120205-48-3

Structure of 120205-48-3

Chemical Structure| 120205-48-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

This compound is an intermediate of monomethyl auristatin E, with anti-tumor activity and potential for development in antibody-drug conjugates (ADCs).

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Monomethyl auristatin E intermediate-1

CAS No. :120205-48-3
Formula : C14H30ClNO3
M.W : 295.85
SMILES Code : CC[C@H](C)[C@H](NC)[C@H](OC)CC(OC(C)(C)C)=O.[H]Cl
MDL No. :MFCD19688575
InChI Key :JRXGCIIOQALIMZ-LWEGJDAASA-N
Pubchem ID :14730240

Safety of Monomethyl auristatin E intermediate-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Monomethyl auristatin E intermediate-1 serves as a precursor in the synthesis of Monomethyl auristatin E (MMAE), a potent inhibitor of microtubules/tubulin that displays significant anticancer activity. MMAE is extensively employed as the cytotoxic payload in antibody-drug conjugates (ADCs), enhancing the targeted destruction of cancer cells[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.38mL

0.68mL

0.34mL

16.90mL

3.38mL

1.69mL

33.80mL

6.76mL

3.38mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories